Gross margin expanded by 240 basis points to 25.1% due to favorable program mix.
Operating earnings grew 30.5% year-over-year to $77 million.
Bookings declined 10.7%, with a sharp 35.9% drop in the ASC segment.
Repaid $191 million term loan and secured a new $500 million revolving facility.
The Q1 2026 filing presents a company at a crossroads, balancing impressive short-term margin gains against deteriorating forward-looking indicators. While the immediate income statement reflects a 'margin miracle' driven by operational leverage and program execution, the decline in new bookings and the high proportion of unfunded backlog suggest a potential slowdown in momentum. The repayment of long-term debt is a positive step for the balance sheet, but the rapid decline in cash reserves warrants investor attention. Ultimately, the investment thesis hinges on whether DRS can stabilize its booking trends in the ASC segment and navigate the inherent risks of its fixed-price contract heavy portfolio. The company's ability to maintain its current trajectory will depend heavily on the FY2027 budget enactment and its success in converting its massive backlog into funded, high-margin revenue streams.